During the past decade, Beskidzkie Centrum Onkologii Im.Jana Pawla Ii conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii" are "Clear-cell Metastatic Renal Cell Carcinoma" (1 trials), "Endometrial Neoplasms" (1 trials), "Lymphoma" (1 trials) and "UC (Urothelial Cancer)" (1 trials). Many other conditions were trialed in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii" in a lesser frequency.

Most popular intervention types in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Doxorubicin" (1 trials), "Epacadostat" (1 trials), "Everolimus" (1 trials) and "Lenvatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Beskidzkie Centrum Onkologii Im.Jana Pawla Ii". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Beskidzkie Centrum Onkologii Im.Jana Pawla Ii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beskidzkie Centrum Onkologii Im.Jana Pawla Ii, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".